1
|
Bsharat S, Monni E, Singh T, Johansson JK, Achanta K, Bertonnier-Brouty L, Schmidt-Christensen A, Holmberg D, Kokaia Z, Prasad RB, Artner I. MafB-dependent neurotransmitter signaling promotes β cell migration in the developing pancreas. Development 2023; 150:297329. [PMID: 36897571 PMCID: PMC10112931 DOI: 10.1242/dev.201009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2022] [Accepted: 02/22/2023] [Indexed: 03/11/2023]
Abstract
Hormone secretion from pancreatic islets is essential for glucose homeostasis and loss or dysfunction of islet cells is a hallmark of type 2 diabetes. Maf transcription factors are critical for establishing and maintaining adult endocrine cell function. However, during pancreas development, MafB is not only expressed in insulin- and glucagon-producing cells, but also Neurog3+ endocrine progenitor cells suggesting additional functions in cell differentiation and islet formation. Here we report that MafB deficiency impairs β cell clustering and islet formation, but also coincides with loss of neurotransmitter and axon guidance receptor gene expression. Moreover, the observed loss of nicotinic receptor gene expression in human and mouse β cells implied that signaling through these receptors contributes to islet cell migration/formation. Inhibition of nicotinic receptor activity resulted in reduced β cell migration towards autonomic nerves and impaired β cell clustering. These findings highlight a novel function of MafB in controlling neuronal-directed signaling events required for islet formation.
Collapse
Affiliation(s)
- Sara Bsharat
- Lund Stem Cell Center, Lund University, Klinikgatan 26 22184, Lund, Sweden.,Lund University Diabetes Center, Jan Waldenströms gata 35, 214 28, Malmö, Sweden
| | - Emanuela Monni
- Lund Stem Cell Center, Lund University, Klinikgatan 26 22184, Lund, Sweden
| | - Tania Singh
- Lund Stem Cell Center, Lund University, Klinikgatan 26 22184, Lund, Sweden.,Lund University Diabetes Center, Jan Waldenströms gata 35, 214 28, Malmö, Sweden
| | - Jenny K Johansson
- Lund Stem Cell Center, Lund University, Klinikgatan 26 22184, Lund, Sweden.,Lund University Diabetes Center, Jan Waldenströms gata 35, 214 28, Malmö, Sweden
| | - Kavya Achanta
- Lund Stem Cell Center, Lund University, Klinikgatan 26 22184, Lund, Sweden.,Lund University Diabetes Center, Jan Waldenströms gata 35, 214 28, Malmö, Sweden
| | - Ludivine Bertonnier-Brouty
- Lund Stem Cell Center, Lund University, Klinikgatan 26 22184, Lund, Sweden.,Lund University Diabetes Center, Jan Waldenströms gata 35, 214 28, Malmö, Sweden
| | | | - Dan Holmberg
- Lund University Diabetes Center, Jan Waldenströms gata 35, 214 28, Malmö, Sweden
| | - Zaal Kokaia
- Lund Stem Cell Center, Lund University, Klinikgatan 26 22184, Lund, Sweden
| | - Rashmi B Prasad
- Lund University Diabetes Center, Jan Waldenströms gata 35, 214 28, Malmö, Sweden
| | - Isabella Artner
- Lund Stem Cell Center, Lund University, Klinikgatan 26 22184, Lund, Sweden.,Lund University Diabetes Center, Jan Waldenströms gata 35, 214 28, Malmö, Sweden
| |
Collapse
|
2
|
Bacos K, Perfilyev A, Karagiannopoulos A, Cowan E, Ofori JK, Bertonnier-Brouty L, Rönn T, Lindqvist A, Luan C, Ruhrmann S, Ngara M, Nilsson Å, Gheibi S, Lyons CL, Lagerstedt JO, Barghouth M, Esguerra JL, Volkov P, Fex M, Mulder H, Wierup N, Krus U, Artner I, Eliasson L, Prasad RB, Cataldo LR, Ling C. Type 2 diabetes candidate genes, including PAX5, cause impaired insulin secretion in human pancreatic islets. J Clin Invest 2023; 133:163612. [PMID: 36656641 PMCID: PMC9927941 DOI: 10.1172/jci163612] [Citation(s) in RCA: 7] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2022] [Accepted: 01/05/2023] [Indexed: 01/20/2023] Open
Abstract
Type 2 diabetes (T2D) is caused by insufficient insulin secretion from pancreatic β cells. To identify candidate genes contributing to T2D pathophysiology, we studied human pancreatic islets from approximately 300 individuals. We found 395 differentially expressed genes (DEGs) in islets from individuals with T2D, including, to our knowledge, novel (OPRD1, PAX5, TET1) and previously identified (CHL1, GLRA1, IAPP) candidates. A third of the identified expression changes in islets may predispose to diabetes, as expression of these genes associated with HbA1c in individuals not previously diagnosed with T2D. Most DEGs were expressed in human β cells, based on single-cell RNA-Seq data. Additionally, DEGs displayed alterations in open chromatin and associated with T2D SNPs. Mouse KO strains demonstrated that the identified T2D-associated candidate genes regulate glucose homeostasis and body composition in vivo. Functional validation showed that mimicking T2D-associated changes for OPRD1, PAX5, and SLC2A2 impaired insulin secretion. Impairments in Pax5-overexpressing β cells were due to severe mitochondrial dysfunction. Finally, we discovered PAX5 as a potential transcriptional regulator of many T2D-associated DEGs in human islets. Overall, we have identified molecular alterations in human pancreatic islets that contribute to β cell dysfunction in T2D pathophysiology.
Collapse
Affiliation(s)
- Karl Bacos
- Epigenetics and Diabetes Unit, Department of Clinical Sciences and
| | | | - Alexandros Karagiannopoulos
- Unit of Islet Cell Exocytosis, Department of Clinical Sciences, Lund University Diabetes Centre, Scania University Hospital, Malmö, Scania, Sweden
| | - Elaine Cowan
- Unit of Islet Cell Exocytosis, Department of Clinical Sciences, Lund University Diabetes Centre, Scania University Hospital, Malmö, Scania, Sweden
| | - Jones K. Ofori
- Epigenetics and Diabetes Unit, Department of Clinical Sciences and
| | - Ludivine Bertonnier-Brouty
- Endocrine Cell Differentiation, Department of Laboratory Medicine, Lund Stem Cell Center, Malmö, Scania, Sweden
| | - Tina Rönn
- Epigenetics and Diabetes Unit, Department of Clinical Sciences and
| | - Andreas Lindqvist
- Neuroendocrine Cell Biology, Department of Experimental Medical Science
| | - Cheng Luan
- Unit of Islet Pathophysiology, Department of Clinical Sciences
| | - Sabrina Ruhrmann
- Epigenetics and Diabetes Unit, Department of Clinical Sciences and
| | - Mtakai Ngara
- Neuroendocrine Cell Biology, Department of Experimental Medical Science
| | - Åsa Nilsson
- Human Tissue Lab, Department of Clinical Sciences
| | - Sevda Gheibi
- Molecular Metabolism Unit, Department of Clinical Sciences, and
| | - Claire L. Lyons
- Molecular Metabolism Unit, Department of Clinical Sciences, and
| | - Jens O. Lagerstedt
- Unit of Islet Cell Exocytosis, Department of Clinical Sciences, Lund University Diabetes Centre, Scania University Hospital, Malmö, Scania, Sweden
| | | | - Jonathan L.S. Esguerra
- Unit of Islet Cell Exocytosis, Department of Clinical Sciences, Lund University Diabetes Centre, Scania University Hospital, Malmö, Scania, Sweden
| | - Petr Volkov
- Epigenetics and Diabetes Unit, Department of Clinical Sciences and
| | - Malin Fex
- Molecular Metabolism Unit, Department of Clinical Sciences, and
| | - Hindrik Mulder
- Molecular Metabolism Unit, Department of Clinical Sciences, and
| | - Nils Wierup
- Neuroendocrine Cell Biology, Department of Experimental Medical Science
| | - Ulrika Krus
- Human Tissue Lab, Department of Clinical Sciences
| | - Isabella Artner
- Endocrine Cell Differentiation, Department of Laboratory Medicine, Lund Stem Cell Center, Malmö, Scania, Sweden
| | - Lena Eliasson
- Unit of Islet Cell Exocytosis, Department of Clinical Sciences, Lund University Diabetes Centre, Scania University Hospital, Malmö, Scania, Sweden
| | - Rashmi B. Prasad
- Genomics, Diabetes and Endocrinology, Department of Clinical Sciences, Lund University Diabetes Centre, Scania University Hospital, Malmö, Scania, Sweden.,Institute of Molecular Medicine (FIMM), Helsinki University, Helsinki, Finland
| | - Luis Rodrigo Cataldo
- Molecular Metabolism Unit, Department of Clinical Sciences, and,The Novo Nordisk Foundation Centre for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
| | - Charlotte Ling
- Epigenetics and Diabetes Unit, Department of Clinical Sciences and
| |
Collapse
|
3
|
Cataldo LR, Vishnu N, Singh T, Bertonnier-Brouty L, Bsharat S, Luan C, Renström E, Prasad RB, Fex M, Mulder H, Artner I. The MafA-target gene PPP1R1A regulates GLP1R-mediated amplification of glucose-stimulated insulin secretion in β-cells. Metabolism 2021; 118:154734. [PMID: 33631146 DOI: 10.1016/j.metabol.2021.154734] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/29/2020] [Revised: 02/07/2021] [Accepted: 02/15/2021] [Indexed: 12/11/2022]
Abstract
The amplification of glucose-stimulated insulin secretion (GSIS) through incretin signaling is critical for maintaining physiological glucose levels. Incretins, like glucagon-like peptide 1 (GLP1), are a target of type 2 diabetes drugs aiming to enhance insulin secretion. Here we show that the protein phosphatase 1 inhibitor protein 1A (PPP1R1A), is expressed in β-cells and that its expression is reduced in dysfunctional β-cells lacking MafA and upon acute MafA knock down. MafA is a central regulator of GSIS and β-cell function. We observed a strong correlation of MAFA and PPP1R1A mRNA levels in human islets, moreover, PPP1R1A mRNA levels were reduced in type 2 diabetic islets and positively correlated with GLP1-mediated GSIS amplification. PPP1R1A silencing in INS1 (832/13) β-cells impaired GSIS amplification, PKA-target protein phosphorylation, mitochondrial coupling efficiency and also the expression of critical β-cell marker genes like MafA, Pdx1, NeuroD1 and Pax6. Our results demonstrate that the β-cell transcription factor MafA is required for PPP1R1A expression and that reduced β-cell PPP1R1A levels impaired β-cell function and contributed to β-cell dedifferentiation during type 2 diabetes. Loss of PPP1R1A in type 2 diabetic β-cells may explains the unresponsiveness of type 2 diabetic patients to GLP1R-based treatments.
Collapse
Affiliation(s)
- Luis Rodrigo Cataldo
- Endocrine Cell Differentiation and Function group, Stem Cell Centre, Lund University, Sweden; Lund University Diabetes Centre, Clinical Research Center, Sweden.
| | - Neelanjan Vishnu
- Lund University Diabetes Centre, Clinical Research Center, Sweden
| | - Tania Singh
- Endocrine Cell Differentiation and Function group, Stem Cell Centre, Lund University, Sweden; Lund University Diabetes Centre, Clinical Research Center, Sweden
| | - Ludivine Bertonnier-Brouty
- Endocrine Cell Differentiation and Function group, Stem Cell Centre, Lund University, Sweden; Lund University Diabetes Centre, Clinical Research Center, Sweden
| | - Sara Bsharat
- Endocrine Cell Differentiation and Function group, Stem Cell Centre, Lund University, Sweden; Lund University Diabetes Centre, Clinical Research Center, Sweden
| | - Cheng Luan
- Lund University Diabetes Centre, Clinical Research Center, Sweden
| | - Erik Renström
- Lund University Diabetes Centre, Clinical Research Center, Sweden
| | - Rashmi B Prasad
- Lund University Diabetes Centre, Clinical Research Center, Sweden; Department of Clinical Sciences in Malmö, Sweden
| | - Malin Fex
- Lund University Diabetes Centre, Clinical Research Center, Sweden
| | - Hindrik Mulder
- Lund University Diabetes Centre, Clinical Research Center, Sweden
| | - Isabella Artner
- Endocrine Cell Differentiation and Function group, Stem Cell Centre, Lund University, Sweden; Lund University Diabetes Centre, Clinical Research Center, Sweden.
| |
Collapse
|
4
|
Bertonnier-Brouty L, Viriot L, Joly T, Charles C. Gene expression patterns associated with dental replacement in the rabbit, a new model for the mammalian dental replacement mechanisms. Dev Dyn 2021; 250:1494-1504. [PMID: 33760336 DOI: 10.1002/dvdy.335] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2020] [Revised: 02/28/2021] [Accepted: 03/23/2021] [Indexed: 12/23/2022] Open
Abstract
BACKGROUND Unlike many vertebrates with continuous dental replacement, mammals have a maximum of two dental generations. Due to the absence of dental replacement in the laboratory mouse, the mechanisms of the mammalian tooth replacement system are poorly known. In this study, we use the European rabbit as a model for mammalian tooth development and replacement. RESULTS We provide data on some key regulators of tooth development. We detected the presence of SOX2 in both the replacement dental lamina and the rudimentary successional dental lamina of unreplaced molars, indicating that SOX2 may not be sufficient to initiate and maintain tooth replacement. We showed that Shh does not seem to be directly involved in tooth replacement. The transient presence of the rudimentary successional dental lamina in the molar allowed us to identify genes that could be essential for the initiation or the maintenance of tooth replacement. Hence, the locations of Sostdc1, RUNX2, and LEF1 vary between the deciduous premolar, the replacement premolar, and the molar, indicating possible roles in tooth replacement. CONCLUSION According to our observations, initiation and the maintenance of tooth replacement correlate with the presence of LEF1+ cells and the absence of both mesenchymal RUNX2 and epithelial Sostdc1+ cells.
Collapse
Affiliation(s)
- Ludivine Bertonnier-Brouty
- Institut de Génomique Fonctionnelle de Lyon, Université de Lyon, CNRS UMR 5242, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Lyon, France
| | - Laurent Viriot
- Institut de Génomique Fonctionnelle de Lyon, Université de Lyon, CNRS UMR 5242, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Lyon, France.,Laboratoire de Biologie tissulaire et Ingénierie thérapeutique, Université de Lyon, CNRS UMR5305, Université Claude Bernard Lyon 1, Lyon, France
| | - Thierry Joly
- Université de Lyon, VetAgro Sup Isara, Marcy l'Etoile, France
| | - Cyril Charles
- Institut de Génomique Fonctionnelle de Lyon, Université de Lyon, CNRS UMR 5242, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Lyon, France
| |
Collapse
|
5
|
Sanz-Navarro M, Seidel K, Sun Z, Bertonnier-Brouty L, Amendt BA, Klein OD, Michon F. Plasticity within the niche ensures the maintenance of a Sox2+ stem cell population in the mouse incisor. Development 2018; 145:dev.155929. [PMID: 29180573 DOI: 10.1242/dev.155929] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2017] [Accepted: 11/15/2017] [Indexed: 12/16/2022]
Abstract
In mice, the incisors grow throughout the animal's life, and this continuous renewal is driven by dental epithelial and mesenchymal stem cells. Sox2 is a principal marker of the epithelial stem cells that reside in the mouse incisor stem cell niche, called the labial cervical loop, but relatively little is known about the role of the Sox2+ stem cell population. In this study, we show that conditional deletion of Sox2 in the embryonic incisor epithelium leads to growth defects and impairment of ameloblast lineage commitment. Deletion of Sox2 specifically in Sox2+ cells during incisor renewal revealed cellular plasticity that leads to the relatively rapid restoration of a Sox2-expressing cell population. Furthermore, we show that Lgr5-expressing cells are a subpopulation of dental Sox2+ cells that also arise from Sox2+ cells during tooth formation. Finally, we show that the embryonic and adult Sox2+ populations are regulated by distinct signalling pathways, which is reflected in their distinct transcriptomic signatures. Together, our findings demonstrate that a Sox2+ stem cell population can be regenerated from Sox2- cells, reinforcing its importance for incisor homeostasis.
Collapse
Affiliation(s)
- Maria Sanz-Navarro
- Helsinki Institute of Life Sciences, Institute of Biotechnology, University of Helsinki, 00014 Helsinki, Finland.,Orthodontics, Department of Oral and Maxillofacial Diseases, University of Helsinki, 00290 Helsinki, Finland
| | - Kerstin Seidel
- Department of Orofacial Sciences and Program in Craniofacial Biology, UCSF, San Francisco, CA 94143, USA
| | - Zhao Sun
- Department of Anatomy and Cell Biology, and the Craniofacial Anomalies Research Center, The University of Iowa, Iowa City, IA 52242, USA
| | - Ludivine Bertonnier-Brouty
- Helsinki Institute of Life Sciences, Institute of Biotechnology, University of Helsinki, 00014 Helsinki, Finland.,Département de Biologie, École Normale Supérieure de Lyon, Université de Lyon, 69007 Lyon, France
| | - Brad A Amendt
- Department of Anatomy and Cell Biology, and the Craniofacial Anomalies Research Center, The University of Iowa, Iowa City, IA 52242, USA.,College of Dentistry, The University of Iowa, Iowa City, IA 52242, USA
| | - Ophir D Klein
- Department of Orofacial Sciences and Program in Craniofacial Biology, UCSF, San Francisco, CA 94143, USA.,Department of Pediatrics and Institute for Human Genetics, University of California San Francisco, San Francisco, CA 94143, USA
| | - Frederic Michon
- Helsinki Institute of Life Sciences, Institute of Biotechnology, University of Helsinki, 00014 Helsinki, Finland .,Keele Medical School and Institute for Science and Technology in Medicine, Keele University, Keele ST5 5BG, UK
| |
Collapse
|